Discovery and Characterisation of 2-Anilino-4-(thiazol-5- yl)pyrimidine Transcriptional CDK Inhibitors as Antican- cer Agents

نویسندگان

  • Shudong Wang
  • Gary Griffiths
  • Carol A. Midgley
  • Anna L. Barnett
  • Michael Cooper
  • Joanna Grabarek
  • Laura Ingram
  • Wayne Jackson
  • George Kontopidis
  • Steven J. McClue
  • Campbell McInnes
  • Janice McLachlan
  • Christopher Meades
  • Mokdad Mezna
  • Iain Stuart
  • Mark P. Thomas
  • Daniella I. Zheleva
  • David P. Lane
  • Robert C. Jackson
  • David M. Glover
  • David G. Blake
  • Peter M. Fischer
چکیده

Cyclacel Limited, Dundee DD1 5JJ, Scotland, UK Present address: School of Pharmacy and Centre for Biomolecular Sciences, University of Nottingham, Nottingham NG7 2RD, UK Present address: Veterinary School, University of Thessaly, Karditsa 43100, Greece Present address: South Carolina College of Pharmacy, University of South Carolina, Columbia, SC 29208, USA *Correspondence: [email protected] (D.G.B), [email protected] (P.M.F)

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Discovery and characterization of 2-anilino-4- (thiazol-5-yl)pyrimidine transcriptional CDK inhibitors as anticancer agents.

The main difficulty in the development of ATP antagonist kinase inhibitors is target specificity, since the ATP-binding motif is present in many proteins. We introduce a strategy that has allowed us to identify compounds from a kinase inhibitor library that block the cyclin-dependent kinases responsible for regulating transcription, i.e., CDK7 and especially CDK9. The screening cascade employs ...

متن کامل

Comparative Structural and Functional Studies of 4-(Thiazol-5-yl)-2-(phenylamino)pyrimidine-5-carbonitrile CDK9 Inhibitors Suggest the Basis for Isotype Selectivity

Cyclin-dependent kinase 9/cyclin T, the protein kinase heterodimer that constitutes positive transcription elongation factor b, is a well-validated target for treatment of several diseases, including cancer and cardiac hypertrophy. In order to aid inhibitor design and rationalize the basis for CDK9 selectivity, we have studied the CDK-binding properties of six different members of a 4-(thiazol-...

متن کامل

Synthesis, Radioiodination and Biodistribution Evaluation of 5-(2-amimo-4-styryl pyrimidine-4-yl)-4-methoxybenzofuran-6-ol

This study describes the organic synthesis of 5-(2-amimo-4-styryl pyrimidine-4-yl)-4-methoxy benzofuran-6-ol (SPBF) as an example of a benzofuran derivative used as a new series of amyloid imaging agents. These benzofuran derivatives may be useful amyloid imaging agents for detecting B-amyloid plagues in the brain of Alzheimer’s disease. The precursor is 1-[6-hydroxy-4-methoxybenzofuran-5-yl]-p...

متن کامل

Discovery of N-phenyl-4-(thiazol-5-yl)pyrimidin-2-amine aurora kinase inhibitors.

Through cell-based screening of our kinase-directed compound collection, we discovered that a subset of N-phenyl-4-(thiazol-5-yl)pyrimidin-2-amines were potent cytotoxic agents against cancer cell lines, suppressed mitotic histone H3 phosphorylation, and caused aberrant mitotic phenotypes. It was subsequently established that these compounds were in fact potent inhibitors of aurora A and B kina...

متن کامل

Synthesis of some new 1,3-thiazolyldiphenyl amine derivative and evaluation of their antibacterial effects

In a search for new leads towards potent antibacterial agents, an array of novel N-[2-(3 ́chloro-2 ́-oxo-4 ́-substitutedaryl-1-azetidinyl)-1-3-thiazol-4-yl]diphenylamine 4(a-e) and N-[2-(2 ́substitutedaryl-4 ́-oxo-1 ́3 ́-thiazolidin-3 ́-yl)-1,3-thiazol-4-yl]diphenylamine 5(a-e) have been synthesized from N-(2-substitutedbenzylidenylimino-1,3-thiazol-4-yl)diphenylamine 3(a-e). Structure of all the synth...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2010